APO Research
Talk to an analyst

APO RESEARCH · REPORT

Influenza Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Influenza Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025197 pages

Choose your research edition.

Industry ResearchInfluenza Treatment Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Influenza Treatment Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Influenza Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Influenza Treatment Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Influenza Treatment Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Influenza Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Influenza Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Influenza Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Influenza Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Influenza Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Influenza Treatment include Sanofi, Novartis AG, GSK plc., Daiichi Sankyo, AstraZeneca, Viatris Inc. (Mylan), Teva Pharmaceutical Industries Ltd., Roche Holding and NATCO Pharma Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Influenza Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Influenza Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Influenza Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Influenza Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Influenza Treatment Segment by Company

Sanofi

Novartis AG

GSK plc.

Daiichi Sankyo

AstraZeneca

Viatris Inc. (Mylan)

Teva Pharmaceutical Industries Ltd.

Roche Holding

NATCO Pharma Limited

Gilead Sciences

BioCryst Pharmaceuticals

Influenza Treatment Segment by Type

Zanamivir

Peramivir

Oseltamivir Phosphate

Baloxavir Marboxil

Others

Influenza Treatment Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Influenza Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Influenza Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Influenza Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Influenza Treatment industry.

Chapter 3: Detailed analysis of Influenza Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Influenza Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Influenza Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Zanamivir Table 3. Key Players of Peramivir Table 4. Key Players of Oseltamivir Phosphate Table 3. Key Players of Baloxavir Marboxil Table 4. Key Players of Others Table 5. Global Influenza Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Hospital Pharmacies Table 7. Key Players of Online Pharmacies Table 8. Key Players of Retail Pharmacies Table 9. Global Influenza Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Influenza Treatment Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Influenza Treatment Market Share by Region (2021-2026) Table 12. Global Influenza Treatment Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Influenza Treatment Market Share by Region (2027-2032) Table 14. Influenza Treatment Industry Trends Table 15. Influenza Treatment Industry Drivers Table 16. Influenza Treatment Industry Opportunities and Challenges Table 17. Influenza Treatment Industry Restraints Table 18. Global Influenza Treatment Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Influenza Treatment Revenue Market Share by Company (2021-2026) Table 20. Global Influenza Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Influenza Treatment Key Company Head Office and Area Served Table 22. Global Influenza Treatment Company, Product Type & Application Table 23. Global Influenza Treatment Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Influenza Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Influenza Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Influenza Treatment Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Influenza Treatment Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Influenza Treatment Revenue Market Share by Type (2021-2026) Table 30. Global Influenza Treatment Revenue Market Share by Type (2027-2032) Table 31. Global Influenza Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Influenza Treatment Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Influenza Treatment Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Influenza Treatment Revenue Market Share by Application (2021-2026) Table 35. Global Influenza Treatment Revenue Market Share by Application (2027-2032) Table 36. Sanofi Company Information Table 37. Sanofi Business Overview Table 38. Sanofi Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Sanofi Influenza Treatment Product Portfolio Table 40. Sanofi Recent Development Table 41. Novartis AG Company Information Table 42. Novartis AG Business Overview Table 43. Novartis AG Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Novartis AG Influenza Treatment Product Portfolio Table 45. Novartis AG Recent Development Table 46. GSK plc. Company Information Table 47. GSK plc. Business Overview Table 48. GSK plc. Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. GSK plc. Influenza Treatment Product Portfolio Table 50. GSK plc. Recent Development Table 51. Daiichi Sankyo Company Information Table 52. Daiichi Sankyo Business Overview Table 53. Daiichi Sankyo Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Daiichi Sankyo Influenza Treatment Product Portfolio Table 55. Daiichi Sankyo Recent Development Table 56. AstraZeneca Company Information Table 57. AstraZeneca Business Overview Table 58. AstraZeneca Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. AstraZeneca Influenza Treatment Product Portfolio Table 60. AstraZeneca Recent Development Table 61. Viatris Inc. (Mylan) Company Information Table 62. Viatris Inc. (Mylan) Business Overview Table 63. Viatris Inc. (Mylan) Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Viatris Inc. (Mylan) Influenza Treatment Product Portfolio Table 65. Viatris Inc. (Mylan) Recent Development Table 66. Teva Pharmaceutical Industries Ltd. Company Information Table 67. Teva Pharmaceutical Industries Ltd. Business Overview Table 68. Teva Pharmaceutical Industries Ltd. Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Teva Pharmaceutical Industries Ltd. Influenza Treatment Product Portfolio Table 70. Teva Pharmaceutical Industries Ltd. Recent Development Table 71. Roche Holding Company Information Table 72. Roche Holding Business Overview Table 73. Roche Holding Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Roche Holding Influenza Treatment Product Portfolio Table 75. Roche Holding Recent Development Table 76. NATCO Pharma Limited Company Information Table 77. NATCO Pharma Limited Business Overview Table 78. NATCO Pharma Limited Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. NATCO Pharma Limited Influenza Treatment Product Portfolio Table 80. NATCO Pharma Limited Recent Development Table 81. Gilead Sciences Company Information Table 82. Gilead Sciences Business Overview Table 83. Gilead Sciences Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Gilead Sciences Influenza Treatment Product Portfolio Table 85. Gilead Sciences Recent Development Table 86. BioCryst Pharmaceuticals Company Information Table 87. BioCryst Pharmaceuticals Business Overview Table 88. BioCryst Pharmaceuticals Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. BioCryst Pharmaceuticals Influenza Treatment Product Portfolio Table 90. BioCryst Pharmaceuticals Recent Development Table 91. North America Influenza Treatment Market Size by Type (2021-2026) & (US$ Million) Table 92. North America Influenza Treatment Market Size by Type (2027-2032) & (US$ Million) Table 93. North America Influenza Treatment Market Size by Application (2021-2026) & (US$ Million) Table 94. North America Influenza Treatment Market Size by Application (2027-2032) & (US$ Million) Table 95. North America Influenza Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Influenza Treatment Market Size by Country (2021-2026) Table 97. North America Influenza Treatment Market Size by Country (2027-2032) Table 98. Europe Influenza Treatment Market Size by Type (2021-2026) & (US$ Million) Table 99. Europe Influenza Treatment Market Size by Type (2027-2032) & (US$ Million) Table 100. Europe Influenza Treatment Market Size by Application (2021-2026) & (US$ Million) Table 101. Europe Influenza Treatment Market Size by Application (2027-2032) & (US$ Million) Table 102. Europe Influenza Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Influenza Treatment Market Size by Country (2021-2026) Table 104. Europe Influenza Treatment Market Size by Country (2027-2032) Table 105. China Influenza Treatment Market Size by Type (2021-2026) & (US$ Million) Table 106. China Influenza Treatment Market Size by Type (2027-2032) & (US$ Million) Table 107. China Influenza Treatment Market Size by Application (2021-2026) & (US$ Million) Table 108. China Influenza Treatment Market Size by Application (2027-2032) & (US$ Million) Table 109. Asia Influenza Treatment Market Size by Type (2021-2026) & (US$ Million) Table 110. Asia Influenza Treatment Market Size by Type (2027-2032) & (US$ Million) Table 111. Asia Influenza Treatment Market Size by Application (2021-2026) & (US$ Million) Table 112. Asia Influenza Treatment Market Size by Application (2027-2032) & (US$ Million) Table 113. Asia Influenza Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Asia Influenza Treatment Market Size by Country (2021-2026) Table 115. Asia Influenza Treatment Market Size by Country (2027-2032) Table 116. South America, Middle East & Africa Influenza Treatment Market Size by Type (2021-2026) & (US$ Million) Table 117. South America, Middle East & Africa Influenza Treatment Market Size by Type (2027-2032) & (US$ Million) Table 118. South America, Middle East & Africa Influenza Treatment Market Size by Application (2021-2026) & (US$ Million) Table 119. South America, Middle East & Africa Influenza Treatment Market Size by Application (2027-2032) & (US$ Million) Table 120. South America, Middle East & Africa Influenza Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. South America, Middle East & Africa Influenza Treatment Market Size by Country (2021-2026) Table 122. South America, Middle East & Africa Influenza Treatment Market Size by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Influenza Treatment Product Image Figure 2. Global Influenza Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Influenza Treatment Market Share by Type: 2025 VS 2032 Figure 4. Zanamivir Image Figure 5. Peramivir Image Figure 6. Oseltamivir Phosphate Image Figure 7. Baloxavir Marboxil Image Figure 8. Others Image Figure 9. Global Influenza Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Influenza Treatment Market Share by Application: 2025 VS 2032 Figure 11. Hospital Pharmacies Image Figure 12. Online Pharmacies Image Figure 13. Retail Pharmacies Image Figure 14. Global Influenza Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 16. Global Influenza Treatment Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Influenza Treatment Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Influenza Treatment Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Influenza Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Influenza Treatment Revenue Market Share by Type (2021-2032) Figure 23. Global Influenza Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Influenza Treatment Revenue Market Share by Application (2021-2032) Figure 25. North America Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 26. North America Influenza Treatment Market Share by Type (2021-2032) Figure 27. North America Influenza Treatment Market Share by Application (2021-2032) Figure 28. North America Influenza Treatment Market Share by Country (2021-2032) Figure 29. United States Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Canada Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 32. Europe Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 33. Europe Influenza Treatment Market Share by Type (2021-2032) Figure 34. Europe Influenza Treatment Market Share by Application (2021-2032) Figure 35. Europe Influenza Treatment Market Share by Country (2021-2032) Figure 36. Germany Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 37. France Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Italy Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 40. Russia Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 42. China Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 43. China Influenza Treatment Market Share by Type (2021-2032) Figure 44. China Influenza Treatment Market Share by Application (2021-2032) Figure 45. Asia Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 46. Asia Influenza Treatment Market Share by Type (2021-2032) Figure 47. Asia Influenza Treatment Market Share by Application (2021-2032) Figure 48. Asia Influenza Treatment Market Share by Country (2021-2032) Figure 49. Japan Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 53. India Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 54. Australia Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Influenza Treatment Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Influenza Treatment Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Influenza Treatment Market Share by Country (2021-2032) Figure 59. Brazil Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 64. UAE Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 66. Chile Influenza Treatment Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Zanamivir
  • Peramivir
  • Oseltamivir Phosphate
  • Baloxavir Marboxil
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Sanofi
  • Novartis AG
  • GSK plc.
  • Daiichi Sankyo
  • AstraZeneca
  • Viatris Inc. (Mylan)
  • Teva Pharmaceutical Industries Ltd.
  • Roche Holding
  • NATCO Pharma Limited
  • Gilead Sciences
  • BioCryst Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Influenza Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Zanamivir
  5. 1.2.3 Peramivir
  6. 1.2.4 Oseltamivir Phosphate
  7. 1.2.5 Baloxavir Marboxil
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Influenza Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital Pharmacies
  12. 1.3.3 Online Pharmacies
  13. 1.3.4 Retail Pharmacies
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Influenza Treatment Growth Trends by Region
  16. 1.5.1 Global Influenza Treatment Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Influenza Treatment Market Size by Region (2021-2026)
  18. 1.5.3 Influenza Treatment Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Influenza Treatment Market Dynamics
  1. 2.1 Influenza Treatment Industry Trends
  2. 2.2 Influenza Treatment Industry Drivers
  3. 2.3 Influenza Treatment Industry Opportunities and Challenges
  4. 2.4 Influenza Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Influenza Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Influenza Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Influenza Treatment Key Company Head office and Area Served
  4. 3.4 Global Influenza Treatment Company, Product Type & Application
  5. 3.5 Global Influenza Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Influenza Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Influenza Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Influenza Treatment Tier 1, Tier 2, and Tier 3
4 Influenza Treatment Market by Type
  1. 4.1 Global Influenza Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Influenza Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Influenza Treatment Market Size Share by Type (2021-2032)
5 Influenza Treatment Market by Application
  1. 5.1 Global Influenza Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Influenza Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Influenza Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Sanofi Influenza Treatment Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Novartis AG
  8. 6.2.1 Novartis AG Company Information
  9. 6.2.2 Novartis AG Business Overview
  10. 6.2.3 Novartis AG Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Novartis AG Influenza Treatment Product Portfolio
  12. 6.2.5 Novartis AG Recent Developments
  13. 6.3 GSK plc.
  14. 6.3.1 GSK plc. Company Information
  15. 6.3.2 GSK plc. Business Overview
  16. 6.3.3 GSK plc. Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 GSK plc. Influenza Treatment Product Portfolio
  18. 6.3.5 GSK plc. Recent Developments
  19. 6.4 Daiichi Sankyo
  20. 6.4.1 Daiichi Sankyo Company Information
  21. 6.4.2 Daiichi Sankyo Business Overview
  22. 6.4.3 Daiichi Sankyo Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Daiichi Sankyo Influenza Treatment Product Portfolio
  24. 6.4.5 Daiichi Sankyo Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 AstraZeneca Influenza Treatment Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 Viatris Inc. (Mylan)
  32. 6.6.1 Viatris Inc. (Mylan) Company Information
  33. 6.6.2 Viatris Inc. (Mylan) Business Overview
  34. 6.6.3 Viatris Inc. (Mylan) Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Viatris Inc. (Mylan) Influenza Treatment Product Portfolio
  36. 6.6.5 Viatris Inc. (Mylan) Recent Developments
  37. 6.7 Teva Pharmaceutical Industries Ltd.
  38. 6.7.1 Teva Pharmaceutical Industries Ltd. Company Information
  39. 6.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
  40. 6.7.3 Teva Pharmaceutical Industries Ltd. Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Teva Pharmaceutical Industries Ltd. Influenza Treatment Product Portfolio
  42. 6.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  43. 6.8 Roche Holding
  44. 6.8.1 Roche Holding Company Information
  45. 6.8.2 Roche Holding Business Overview
  46. 6.8.3 Roche Holding Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Roche Holding Influenza Treatment Product Portfolio
  48. 6.8.5 Roche Holding Recent Developments
  49. 6.9 NATCO Pharma Limited
  50. 6.9.1 NATCO Pharma Limited Company Information
  51. 6.9.2 NATCO Pharma Limited Business Overview
  52. 6.9.3 NATCO Pharma Limited Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 NATCO Pharma Limited Influenza Treatment Product Portfolio
  54. 6.9.5 NATCO Pharma Limited Recent Developments
  55. 6.10 Gilead Sciences
  56. 6.10.1 Gilead Sciences Company Information
  57. 6.10.2 Gilead Sciences Business Overview
  58. 6.10.3 Gilead Sciences Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Gilead Sciences Influenza Treatment Product Portfolio
  60. 6.10.5 Gilead Sciences Recent Developments
  61. 6.11 BioCryst Pharmaceuticals
  62. 6.11.1 BioCryst Pharmaceuticals Company Information
  63. 6.11.2 BioCryst Pharmaceuticals Business Overview
  64. 6.11.3 BioCryst Pharmaceuticals Influenza Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 BioCryst Pharmaceuticals Influenza Treatment Product Portfolio
  66. 6.11.5 BioCryst Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Influenza Treatment Market Size (2021-2032)
  2. 7.2 North America Influenza Treatment Market Size by Type
  3. 7.2.1 North America Influenza Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Influenza Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Influenza Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Influenza Treatment Market Size by Application
  7. 7.3.1 North America Influenza Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Influenza Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Influenza Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Influenza Treatment Market Size by Country
  11. 7.4.1 North America Influenza Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Influenza Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Influenza Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Influenza Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Influenza Treatment Market Size (2021-2032)
  2. 8.2 Europe Influenza Treatment Market Size by Type
  3. 8.2.1 Europe Influenza Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Influenza Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Influenza Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Influenza Treatment Market Size by Application
  7. 8.3.1 Europe Influenza Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Influenza Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Influenza Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Influenza Treatment Market Size by Country
  11. 8.4.1 Europe Influenza Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Influenza Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Influenza Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Influenza Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Influenza Treatment Market Size (2021-2032)
  2. 9.2 China Influenza Treatment Market Size by Type
  3. 9.2.1 China Influenza Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Influenza Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Influenza Treatment Market Share by Type (2021-2032)
  6. 9.3 China Influenza Treatment Market Size by Application
  7. 9.3.1 China Influenza Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Influenza Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Influenza Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Influenza Treatment Market Size (2021-2032)
  2. 10.2 Asia Influenza Treatment Market Size by Type
  3. 10.2.1 Asia Influenza Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Influenza Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Influenza Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Influenza Treatment Market Size by Application
  7. 10.3.1 Asia Influenza Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Influenza Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Influenza Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Influenza Treatment Market Size by Country
  11. 10.4.1 Asia Influenza Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Influenza Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Influenza Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Influenza Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Influenza Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Influenza Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Influenza Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Influenza Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Influenza Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Influenza Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Influenza Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Influenza Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Influenza Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Influenza Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Influenza Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Influenza Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Influenza Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Influenza Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst